Skip to main content
Taylor & Francis Group Logo
    Advanced Search

    Click here to search products using title name,author name and keywords.

    • Login
    • Hi, User  
      • Your Account
      • Logout
      Advanced Search

      Click here to search products using title name,author name and keywords.

      Breadcrumbs Section. Click here to navigate to respective pages.

      Chapter

      Measuring and Interpreting the Efcacy of Nutraceutical Interventions for Age-Related Cognitive Decline
      loading

      Chapter

      Measuring and Interpreting the Efcacy of Nutraceutical Interventions for Age-Related Cognitive Decline

      DOI link for Measuring and Interpreting the Efcacy of Nutraceutical Interventions for Age-Related Cognitive Decline

      Measuring and Interpreting the Efcacy of Nutraceutical Interventions for Age-Related Cognitive Decline book

      Measuring and Interpreting the Efcacy of Nutraceutical Interventions for Age-Related Cognitive Decline

      DOI link for Measuring and Interpreting the Efcacy of Nutraceutical Interventions for Age-Related Cognitive Decline

      Measuring and Interpreting the Efcacy of Nutraceutical Interventions for Age-Related Cognitive Decline book

      Edited ByCon Kerry Kenneth Stough, Andrew Scholey
      BookAdvances in Natural Medicines, Nutraceuticals and Neurocognition

      Click here to navigate to parent product.

      Edition 1st Edition
      First Published 2013
      Imprint CRC Press
      Pages 12
      eBook ISBN 9780429111761
      Share
      Share

      ABSTRACT

      The world’s population is aging rapidly, with the proportion of the population over 60 growing at a rate of around 2% per annum in the developed world (United Nations, 2009). In the most developed regions, 264 million people (21% of the population) were estimated to be 60 years and older in 2009, with this gure projected to increase to around 416 million (33% of the population) by the year 2050 (United Nations, 2009). A major societal health issue for an aging population is not only the greater incidence of neurodegenerative disorders such as Alzheimer’s disease but also the impact of normal age-related cognitive decline. Up to 50% of adults aged 64 and over have reported difculties with their memory (Reid and MacLullich, 2006). In response to the reality of an aging population, there has been increased research focus in recent years on the development of effective interventions that may ameliorate the declines in cognitive ability.

      T&F logoTaylor & Francis Group logo
      • Policies
        • Privacy Policy
        • Terms & Conditions
        • Cookie Policy
        • Privacy Policy
        • Terms & Conditions
        • Cookie Policy
      • Journals
        • Taylor & Francis Online
        • CogentOA
        • Taylor & Francis Online
        • CogentOA
      • Corporate
        • Taylor & Francis Group
        • Taylor & Francis Group
        • Taylor & Francis Group
        • Taylor & Francis Group
      • Help & Contact
        • Students/Researchers
        • Librarians/Institutions
        • Students/Researchers
        • Librarians/Institutions
      • Connect with us

      Connect with us

      Registered in England & Wales No. 3099067
      5 Howick Place | London | SW1P 1WG © 2022 Informa UK Limited